# RenovoRx (RNXT) — Overview

RNXT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rnxt

## Price

Last close $1.20 on Oct 15, 2026. 52-week range $0.73 – $2.52.

## Company profile

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $2.0M |
| Revenue (quarter) | $909,000.00 |
| Revenue growth (year over year) | 115.40% |
| Gross profit (trailing twelve months) | $1.7M |
| Gross margin | 84.41% |
| Net income (trailing twelve months) | −$12.3M |
| Net income (quarter) | −$2.9M |
| Net income growth (year over year) | -0.55% |
| Net margin | -621.71% |
| Return on equity | -125.23% |
| EPS (trailing twelve months) | −$0.31 |
| Book value per share | $0.20 |
| P/E (trailing twelve months) | — |
| Price to book | 6.0 |
| Debt to assets | 21.73% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is RenovoRx (RNXT) profitable?

No. RenovoRx reported a net loss of $12.3M over the trailing twelve months.

### How much revenue does RenovoRx (RNXT) make?

RenovoRx generated $2.0M in revenue over the trailing twelve months, up 115.40% year over year.

### How do I buy stock in RenovoRx (RNXT)?

RNXT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).